In the past week, RMD stock has gone up by 2.12%, with a monthly gain of 4.06% and a quarterly surge of 15.47%. The volatility ratio for the week is 1.55%, and the volatility levels for the last 30 days are 1.47% for Resmed Inc The simple moving average for the last 20 days is 2.07% for RMD’s stock, with a simple moving average of 7.57% for the last 200 days.
Is It Worth Investing in Resmed Inc (NYSE: RMD) Right Now?
The price-to-earnings ratio for Resmed Inc (NYSE: RMD) is 28.77x, which is above its average ratio. Moreover, the 36-month beta value for RMD is 0.77. Analysts have varying opinions on the stock, with 8 analysts rating it as a “buy,” 4 as “overweight,” 7 as “hold,” and 1 as “sell.”
The public float for RMD is 145.60M and currently, short sellers hold a 6.82% of that float. On June 27, 2025, RMD’s average trading volume was 1.01M shares.
RMD) stock’s latest price update
Resmed Inc (NYSE: RMD) has experienced a decline in its stock price by -0.66 compared to its previous closing price of 257.91. However, the company has seen a gain of 2.12% in its stock price over the last five trading days. zacks.com reported 2025-06-25 that ResMed (RMD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Analysts’ Opinion of RMD
Many brokerage firms have already submitted their reports for RMD stocks, with Morgan Stanley repeating the rating for RMD by listing it as a “Overweight.” The predicted price for RMD in the upcoming period, according to Morgan Stanley is $280 based on the research report published on March 19, 2025 of the current year 2025.
RMD Trading at 5.53% from the 50-Day Moving Average
After a stumble in the market that brought RMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -2.60% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at RMD starting from Farrell Michael J., who sale 8,009 shares at the price of $251.21 back on Jun 09 ’25. After this action, Farrell Michael J. now owns 455,503 shares of Resmed Inc, valued at $2,011,910 using the latest closing price.
Stock Fundamentals for RMD
Current profitability levels for the company are sitting at:
- 0.32 for the present operating margin
- 0.59 for the gross margin
The net margin for Resmed Inc stands at 0.26. The total capital return value is set at 0.24. Equity return is now at value 25.81, with 18.26 for asset returns.
Based on Resmed Inc (RMD), the company’s capital structure generated 0.13 points at debt to capital in total, while cash flow to debt ratio is standing at 1.97. The debt to equity ratio resting at 0.15. The interest coverage ratio of the stock is 226.6.
Currently, EBITDA for the company is 1.53 billion with net debt to EBITDA at -0.05. When we switch over and look at the enterprise to sales, we see a ratio of 7.46. The receivables turnover for the company is 5.53for trailing twelve months and the total asset turnover is 0.66. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.41.
Conclusion
To wrap up, the performance of Resmed Inc (RMD) has been better in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
